Compare · SLP vs TWTR
SLP vs TWTR
Side-by-side comparison of Simulations Plus Inc. (SLP) and Twitter Inc. (TWTR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both SLP and TWTR operate in EDP Services (Technology), so they compete in similar markets.
- TWTR is the larger of the two at $28.20B, about 87.9x SLP ($320.9M).
- SLP has hit the wire 3 times in the past 4 weeks while TWTR has been quiet.
- TWTR has more recent analyst coverage (25 ratings vs 10 for SLP).
- Company
- Simulations Plus Inc.
- Twitter Inc.
- Price
- -
- -
- Market cap
- $320.9M
- $28.20B
- 1M return
- -1.09%
- -
- 1Y return
- -41.97%
- -
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2013
- News (4w)
- 3
- 0
- Recent ratings
- 10
- 25
Simulations Plus Inc.
Simulations Plus, Inc. develops drug discovery and development software for mechanistic modeling and simulation, and prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology worldwide. The company offers GastroPlus, which simulates the absorption, pharmacokinetics (PK), pharmacodynamics, and drug-drug interactions of compounds administered to humans and animals; DDDPlus that simulates in vitro laboratory experiments; and MembranePlus, which simulates laboratory experiments. It also provides PKPlus, a program that provides the functionality needed by pharmaceutical industry scientists to perform the analyses and generate the outputs needed to satisfy regulatory agency requirements for noncompartmental analysis and compartmental PK modelling; ADMET Predictor, a chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, a molecule drawing program or sketcher. In addition, it offers KIWI, a cloud-based web application to organize, process, maintain, and communicate the volume of data and results generated by pharmacologists and scientists over the duration of a drug development program; DILIsym, a quantitative systems pharmacology software; NAFLDsym, a simulation program for analyzing nonalcoholic fatty liver disease; RENAsym for investigating and predicting drug-induced or acute kidney injury; IPFsym, a software tool to treat or cure idiopathic pulmonary fibrosis; and the Monolix Suite, a solution for modeling and simulation. Further, the company provides population modeling and simulation contract research services; and clinical-pharmacology-based consulting services in support of regulatory submissions. It serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. The company was founded in 1996 and is headquartered in Lancaster, California.
Twitter Inc.
Twitter, Inc. operates as a platform for public self-expression and conversation in real time United States, Japan, and internationally. The company offers Twitter, a platform that allows users to consume, create, distribute, and discover content. It also provides promoted products and services, such as promoted tweets, promoted accounts, and promoted trends, which enable its advertisers to promote their brands, products, and services. In addition, the company offers MoPub, a mobile-focused advertising exchange that combines ad serving, ad network mediation, and a real-time bidding exchange into one monetization platform; Twitter Audience platform, an advertising offering that enables advertisers to extend advertising campaigns; Developer and Enterprise solutions, a software-as-a-service platform that enables developers to build products on Twitter; and paid enterprise access for its public data streams. Twitter, Inc. was founded in 2006 and is headquartered in San Francisco, California.
Latest SLP
- Chief Revenue Officer Dibella John Anthony Ii sold $16,500 worth of shares (1,000 units at $16.50) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 87,140 units (SEC Form 4)
- Director Woltosz Walter S sold $261,450 worth of shares (15,000 units at $17.43) as part of a pre-agreed trading plan, decreasing direct ownership by 0.46% to 3,252,800 units (SEC Form 4)
- Simulations Plus to Participate in the 23rd Annual Craig-Hallum Institutional Investor Conference
- President, Services Solutions Fiedler-Kelly Jill exercised 1,000 shares at a strike of $10.05 and sold $16,530 worth of shares (1,000 units at $16.53) as part of a pre-agreed trading plan (SEC Form 4)
- Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows
- Chief Revenue Officer Dibella John Anthony Ii sold $14,980 worth of shares (1,000 units at $14.98) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 88,140 units (SEC Form 4)
- Director Woltosz Walter S sold $226,950 worth of shares (15,000 units at $15.13) as part of a pre-agreed trading plan, decreasing direct ownership by 0.46% to 3,267,800 units (SEC Form 4)
- Director Evans Sharlene was granted 2,117 shares, increasing direct ownership by 14% to 17,173 units (SEC Form 4)
- Director Woltosz Walter S was granted 2,117 shares, increasing direct ownership by 0.06% to 3,282,800 units (SEC Form 4)
- Director Weiner Daniel L was granted 2,117 shares, increasing direct ownership by 15% to 16,547 units (SEC Form 4)
Latest TWTR
- NY Gov Hochul's Latest Crackdown On Illicit Cannabis Operations Has The Big Apple In Its Crosshairs
- Biden's Health Secretary Stalls On Completing Marijuana Review By 4/20
- As Twitter Moves Forward With Cannabis Advertising, Meta Really Should Get With The Program
- Elon Musk's Decision To Allow Cannabis Ads On Twitter: It's A New Frontier And Benzinga Is Part Of It
- Elon Musk Tweets A Simple Yet Powerful Pro-Marijuana Message, Reaches Millions Around The World
- Google Ads For Cannabis: New Policy Change To Allow Advertising In These States
- Boobs And Bud: Is It Time To Go Back To Tumblr? Weed Friendly Social Network Allows Nudity Again
- SEC Form 4: Agrawal Parag returned 927,806 shares to the company, closing all direct ownership in the company
- SEC Form 4: Gadde Vijaya returned 1,097,589 shares to the company, closing all direct ownership in the company
- SEC Form 4: Segal Ned D. returned 945,546 shares to the company, closing all direct ownership in the company